Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG

BACKGROUND: Presently melanoma still lacks adequate treatment options for metastatic disease. While melanoma is exceptionally challenging to standard regimens, it is suited for treatment with immunotherapy based on its immunogenicity. Since treatment-related skin depigmentation is considered a favou...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Boorn, Jasper G., Konijnenberg, Debby, Tjin, Esther P. M., Picavet, Daisy I., Meeuwenoord, Nico J., Filippov, Dmitri V., van der Veen, J. P. Wietze, Bos, Jan D., Melief, Cornelis J. M., Luiten, Rosalie M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869359/
https://www.ncbi.nlm.nih.gov/pubmed/20498710
http://dx.doi.org/10.1371/journal.pone.0010626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869359/
https://www.ncbi.nlm.nih.gov/pubmed/20498710
http://dx.doi.org/10.1371/journal.pone.0010626

Ejemplares similares